Cytokine profiles in schizophrenic patients treated with risperidone: A 3-month follow-up study

Carlo L. Cazzullo, Emilio Sacchetti, Alessandro Galluzzo, Adelaide Panariello, Andrea Adorni, Marco Pegoraro, Simona Bosis, Fulvia Colombo, Daria Trabattoni, Arianna Zagliani, Mario Clerici

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

An increasing body of evidence suggests a role for the immune system in the pathogenesis of schizophrenia. The information concerning the effects of antipsychotics on cytokine profiles are limited and often controversial in particular regarding novel antipsychotics. The authors first investigated the production of various cytokines [interleukin (IL)-2, IL-4, IL-10, interferon (INF)-γ] in drug-free (n=12) and drug-naive (n=3) schizophrenic patients and in healthy controls (n=33) and then the modifications of cytokines values during a 3-month period of treatment with risperidone. In the baseline condition, the production of IL-2 and INF-γ was significantly higher (P=.023 and .026, respectively) in patients than in controls. In the same patients, the use of risperidone was associated with augmented IL-10 (a suppressor of Type 1 cytokines) and decreased INF-γ production. This modification suggests that clinical improvement is associated with a reduction in the inflammatory-like situation present in not currently treated schizophrenic patients.

Original languageEnglish
Pages (from-to)33-39
Number of pages7
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume26
Issue number1
DOIs
Publication statusPublished - 2002

Fingerprint

Risperidone
Interferons
Cytokines
Interleukin-10
Antipsychotic Agents
Interleukin-2
Interleukin-4
Pharmaceutical Preparations
Immune System
Schizophrenia
Therapeutics

Keywords

  • Antipsychotics
  • Cytokines
  • Risperidone
  • Schizophrenia

ASJC Scopus subject areas

  • Biological Psychiatry
  • Pharmacology

Cite this

Cytokine profiles in schizophrenic patients treated with risperidone : A 3-month follow-up study. / Cazzullo, Carlo L.; Sacchetti, Emilio; Galluzzo, Alessandro; Panariello, Adelaide; Adorni, Andrea; Pegoraro, Marco; Bosis, Simona; Colombo, Fulvia; Trabattoni, Daria; Zagliani, Arianna; Clerici, Mario.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 26, No. 1, 2002, p. 33-39.

Research output: Contribution to journalArticle

Cazzullo, CL, Sacchetti, E, Galluzzo, A, Panariello, A, Adorni, A, Pegoraro, M, Bosis, S, Colombo, F, Trabattoni, D, Zagliani, A & Clerici, M 2002, 'Cytokine profiles in schizophrenic patients treated with risperidone: A 3-month follow-up study', Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 26, no. 1, pp. 33-39. https://doi.org/10.1016/S0278-5846(01)00221-4
Cazzullo, Carlo L. ; Sacchetti, Emilio ; Galluzzo, Alessandro ; Panariello, Adelaide ; Adorni, Andrea ; Pegoraro, Marco ; Bosis, Simona ; Colombo, Fulvia ; Trabattoni, Daria ; Zagliani, Arianna ; Clerici, Mario. / Cytokine profiles in schizophrenic patients treated with risperidone : A 3-month follow-up study. In: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2002 ; Vol. 26, No. 1. pp. 33-39.
@article{a6af781e345c4f6ca684baa559e00b37,
title = "Cytokine profiles in schizophrenic patients treated with risperidone: A 3-month follow-up study",
abstract = "An increasing body of evidence suggests a role for the immune system in the pathogenesis of schizophrenia. The information concerning the effects of antipsychotics on cytokine profiles are limited and often controversial in particular regarding novel antipsychotics. The authors first investigated the production of various cytokines [interleukin (IL)-2, IL-4, IL-10, interferon (INF)-γ] in drug-free (n=12) and drug-naive (n=3) schizophrenic patients and in healthy controls (n=33) and then the modifications of cytokines values during a 3-month period of treatment with risperidone. In the baseline condition, the production of IL-2 and INF-γ was significantly higher (P=.023 and .026, respectively) in patients than in controls. In the same patients, the use of risperidone was associated with augmented IL-10 (a suppressor of Type 1 cytokines) and decreased INF-γ production. This modification suggests that clinical improvement is associated with a reduction in the inflammatory-like situation present in not currently treated schizophrenic patients.",
keywords = "Antipsychotics, Cytokines, Risperidone, Schizophrenia",
author = "Cazzullo, {Carlo L.} and Emilio Sacchetti and Alessandro Galluzzo and Adelaide Panariello and Andrea Adorni and Marco Pegoraro and Simona Bosis and Fulvia Colombo and Daria Trabattoni and Arianna Zagliani and Mario Clerici",
year = "2002",
doi = "10.1016/S0278-5846(01)00221-4",
language = "English",
volume = "26",
pages = "33--39",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Cytokine profiles in schizophrenic patients treated with risperidone

T2 - A 3-month follow-up study

AU - Cazzullo, Carlo L.

AU - Sacchetti, Emilio

AU - Galluzzo, Alessandro

AU - Panariello, Adelaide

AU - Adorni, Andrea

AU - Pegoraro, Marco

AU - Bosis, Simona

AU - Colombo, Fulvia

AU - Trabattoni, Daria

AU - Zagliani, Arianna

AU - Clerici, Mario

PY - 2002

Y1 - 2002

N2 - An increasing body of evidence suggests a role for the immune system in the pathogenesis of schizophrenia. The information concerning the effects of antipsychotics on cytokine profiles are limited and often controversial in particular regarding novel antipsychotics. The authors first investigated the production of various cytokines [interleukin (IL)-2, IL-4, IL-10, interferon (INF)-γ] in drug-free (n=12) and drug-naive (n=3) schizophrenic patients and in healthy controls (n=33) and then the modifications of cytokines values during a 3-month period of treatment with risperidone. In the baseline condition, the production of IL-2 and INF-γ was significantly higher (P=.023 and .026, respectively) in patients than in controls. In the same patients, the use of risperidone was associated with augmented IL-10 (a suppressor of Type 1 cytokines) and decreased INF-γ production. This modification suggests that clinical improvement is associated with a reduction in the inflammatory-like situation present in not currently treated schizophrenic patients.

AB - An increasing body of evidence suggests a role for the immune system in the pathogenesis of schizophrenia. The information concerning the effects of antipsychotics on cytokine profiles are limited and often controversial in particular regarding novel antipsychotics. The authors first investigated the production of various cytokines [interleukin (IL)-2, IL-4, IL-10, interferon (INF)-γ] in drug-free (n=12) and drug-naive (n=3) schizophrenic patients and in healthy controls (n=33) and then the modifications of cytokines values during a 3-month period of treatment with risperidone. In the baseline condition, the production of IL-2 and INF-γ was significantly higher (P=.023 and .026, respectively) in patients than in controls. In the same patients, the use of risperidone was associated with augmented IL-10 (a suppressor of Type 1 cytokines) and decreased INF-γ production. This modification suggests that clinical improvement is associated with a reduction in the inflammatory-like situation present in not currently treated schizophrenic patients.

KW - Antipsychotics

KW - Cytokines

KW - Risperidone

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=0036139673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036139673&partnerID=8YFLogxK

U2 - 10.1016/S0278-5846(01)00221-4

DO - 10.1016/S0278-5846(01)00221-4

M3 - Article

C2 - 11853116

AN - SCOPUS:0036139673

VL - 26

SP - 33

EP - 39

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

IS - 1

ER -